Jon Zwinski was named General Manager and Chief Executive Officer in January 2021. Since joining Chiesi USA in 2012, he has held numerous executive positions focused on the growth of the company’s commercial organization across multiple therapeutic categories. Immediately prior to his current role, he served as Senior Vice President of Sales and Head of the Cardiovascular Business Unit.
In his 25+ year career as a pharmaceutical executive, Jon has worked in multiple therapeutic areas, including anesthesia, women’s health, emergency medicine, psychiatry, neurology, neonatology, urology, cardiovascular, and cystic fibrosis. Jon previously held positions at Organon Pharmaceuticals, PDL BioPharma, and EKR Therapeutics, where he was Vice President of Sales before joining Chiesi USA.